ON THE VALUE OF APRICOT KERNEL IN MODERN MEDICINE AND ITS FUTURE DEVELOPMENT

被引：1

作者：

Hu, Qian ^{[1
]}

Chen, Ying-Ying ^{[1
]}

Zhu, Gao-Ying ^{[1
,2
]}

Zhao, Han ^{[3
,4
]}

Wang, Lin ^{[3
,4
]}

Liu, Hui-Min ^{[3
,4
]}

Wuyun, Tana ^{[3
,4
]}

Li, Fang-Dong ^{[3
,4
]}

Zhu, Gao-Pu ^{[1
,3
,4
]}

机构：

[1] Zhengzhou Railway Vocat & Tech Coll, Zhengzhou 451460, Peoples R China

[2] Xiangcheng Cty Peoples Hosp, Xuchang 452670, Peoples R China

[3] Chinese Acad Forestry, Natl Forestry & Grassland Adm, Res Inst Nontimber Forestry, Kernel Apricot Engn & Technol Res Ctr, Zhengzhou 450003, Peoples R China

[4] Natl Forestry & Grassland Adm, Key Lab Nontimber Forest Germplasm Enhancement & U, Zhengzhou 450003, Peoples R China

来源：

PAKISTAN JOURNAL OF BOTANY | 2023年 / 55卷 / 02期

基金：

国家重点研发计划;

关键词：

Apricot kernel; Amygdalin; Corona virus disease 2019 (COVID-19); Modern medicine; BIOMASS ACCUMULATION; AMYGDALIN CONTENT; CANCER; FIBROSIS; EXPRESSION; APOPTOSIS; OIL; L;

D O I：

10.30848/PJB2023-2(8)

中图分类号：

Q94 [植物学];

学科分类号：

071001 ;

摘要：

Apricot kernels are one of the most regularly used traditional Chinese medicinal ingredients in Asia. The medical significance of apricot kernels is highlighted since Traditional Chinese Medicine (TCM) demonstrated its favourable impact when apricot kernels were used in the prevention and treatment of Corona Virus Disease 2019 (COVID-19). Furthermore, apricot kernels are high in fat, protein, dietary fibre, and specific amygdalin, making them a new form of dried fruit in comparison to almond kernels, with a bigger market opportunity. This paper systematically reviewed the active components of apricot kernels and their application in medicine, especially for molecular mechanisms of anti-tumors of amygdalin, providing scientific theoretical foundations for modern medicine treatment with COVID-19-induced lung disease, and for the development of high value-added apricot kernels.

引用

页码：649 / 655

页数：7

共 49 条

[41] Diagnostic value of miR-186-5p for carotid artery stenosis and its predictive significance for future cerebral ischemic event
Lv, Weibo
Zhang, Tao
Zhao, Hongwei
He, Shuang
Li, Bingwei
Gao, Yang
Pan, Wenying
DIAGNOSTIC PATHOLOGY, 2020, 15 (01)
[42] The Potential Dual Role of H2.0-like Homeobox in the Tumorgenesis and Development of Colorectal Cancer and Its Prognostic Value
Chen, Shuo
Zhang, Lin
Wang, Kai
Huo, Jizhen
Zhang, Siqi
Zhang, Xipeng
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 2023
[43] Novel insights into the GCN2 pathway and its targeting. Therapeutic value in cancer and lessons from lung fibrosis development
Piecyk, Marie
Ferraro-Peyret, Carole
Laville, David
Perros, Frederic
Chaveroux, Cedric
FEBS JOURNAL, 2024, 291 (22) : 4867 - 4889
[44] Development of a hybrid peptide dendrimer micellar carrier system and its application in the reformulation of a hydrophobic therapeutic agent derived from traditional Chinese medicine
Jing, Jing
Tupally, Karnaker R.
Kokil, Ganesh R.
Qu, Zhi
Chen, Sibao
Parekh, Harendra S.
RSC ADVANCES, 2019, 9 (05) : 2458 - 2463
[45] Diagnostic significance of serum PP4R1 and its predictive value for the development of chronic complications in patients with type 2 diabetes mellitus
Li, Wenjing
Peng, Lanbo
Yang, Chao
Chen, Guangmin
DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01)
[46] Towards Clinical Development of Scandium Radioisotope Complexes for Use in Nuclear Medicine: Encouraging Prospects with the Chelator 1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic Acid (DOTA) and Its Analogues
Ioannidis, Ioannis
Lefkaritis, George
Georgiades, Savvas N.
Pashalidis, Ioannis
Kontoghiorghes, George J.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (11)
[47] Genomics in personalized cancer medicine and its impact on earlydrug development in China: report from the 6th Annual Meeting of the US Chinese Anti-Cancer Association(USCACA) at the 50th ASCOAnnual Meeting
Wei Zhang
ShiYuan Cheng
LiFang Hou
Li Yan
YunGuang Tong
Chinese Journal of Cancer, 2014, 33 (08) : 371 - 375
[48] Genomics in personalized cancer medicine and its impact on early drug development in China: report from the 6th Annual Meeting of the US Chinese Anti-Cancer Association (USCACA) at the 50th ASCO Annual Meeting
Zhang, Wei
Cheng, Shi-Yuan
Hou, Li-Fang
Yan, Li
Tong, Yun-Guang
CHINESE JOURNAL OF CANCER, 2014, 33 (08) : 371 - 375
[49] Development and validation of a clinical prediction model to estimate the probability of malignancy in solid pancreatic lesions and explore its value in the atypical diagnostic category after endoscopic ultrasound-guided fine-needle aspiration biopsy (EUS-FNA)
Wei, Ning
Shi, Rui Hua
Yu, Ting
TRANSLATIONAL CANCER RESEARCH, 2020, 9 (11) : 6801 - 6810

← 1 2 3 4 5 →